Molex to Acquire Vectura Group, Enhancing Inhalation Drug Delivery Capabilities
Hudson, WI – September 17, 2024 – Molex, the parent company of Phillips Medisize, announced today that it has signed an agreement to acquire Vectura Group Limited, a leader in inhalation drug device design and formulation. The acquisition, facilitated through Molex Asia Holdings LTD., will expand Phillips Medisize's capabilities in drug delivery and solidify its position in the pharmaceutical sector.
